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Research on biological correlates of psychopathology stands to benefit from being interwoven with an empirically
based, quantitative model of mental disorders. Empirically-based classification approaches help to deal effectively
with issues such as comorbidity among diagnoses, which often serve as challenges to interpreting research on
biological correlates. With regard to the mood and anxiety disorders specifically, quantitative research shows how
mood and anxiety disorders are well conceptualized as elements within a broad internalizing spectrum of
psychopathology, such that many putative biological correlates of specific disorders may be better conceptualized
as delineating the pathophysiology of the broader mechanisms underlying multiple disorders.
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The stated goal of the Diagnostic and Statistical Manual for
Mental Disorders (DSM) is threefold: to provide a helpful
guide to clinical practice, to facilitate research and improve
communication among clinicians and researchers, and to
serve as an educational tool for teaching psychopathology
(DSM-IV-R 4th ed., pp xxiii). Historically, DSM began as a
broad set of vignettes that depicted common clinical mani-
festations of mental disorders, but diagnoses listed in early
DSMs were not reliably diagnosed by clinicians, and as a re-
sult had little validity [1]. By introducing explicit sets of
diagnostic criteria, the DSM-III was instrumental in refin-
ing the boundaries of diagnoses so that clinicians were dis-
cussing the same clinical entities, supposedly distinct from
others. DSM-III also introduced exclusionary criteria that
sought to limit overlap between diagnostic sets. DSM-IV
did little to change the basic scheme of the DSM-III, which
had grown to include hundreds of distinct diagnostic cat-
egories. This degree of presumed diagnostic differentiation
often contrasts with clinical experiences, where patients
typically meet criteria for multiple DSM diagnoses, a
phenomenon referred to as comorbidity [2-6], or related
experiences where patients present with symptom config-
urations “not otherwise specified”(NOS), as opposed to* Correspondence: ofrat001@umn.edu
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distribution, and reproduction in any mediumsymptoms that cohere into a clear DSM-defined focal syn-
drome [2]. As a result, questions about the validity of
DSM-IV’s approach to psychodiagnosis are frequently
raised [1,7].Main text
Research focusing on the problem of diagnostic comorbid-
ity has resulted in a literature that has converged on an
empirical model of the meta-structure of common mental
disorders, or the way in which multiple mental disorders
delineate spectrums of interrelated conditions. There is
mounting evidence to suggest that common forms of psy-
chopathology are defined by the higher-order groupings
or spectrums of internalizing and externalizing, and that
this shared underlying meta-structure contributes to the
comorbidity among disorders [8-11]. As shown in Figure 1
[9], internalizing is indicated by unipolar mood disorders
and anxiety disorders, like major depressive disorder, gen-
eralized anxiety disorder, social and specific phobias, and
panic, that load highly on the internalizing factor. External-
izing is indicated by disinhibitory and substance abuse dis-
orders including drug, alcohol, and nicotine dependence,
antisocial personality disorder and antisocial traits, patho-
logical gambling, and conduct disorder. Within the higher-
order internalizing dimension, some studies have revealed
two sub-dimensions: distress, representing unipolar moodntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Path diagram for best-fitting meta-analytic model of the structure of common mental disorders. This figure provides parameter
estimates from the best-fitting model according to a meta-analytic multiple-groups confirmatory factor analysis [9]. All parameter estimates are
standardized and significant, p < .05. Reprinted from Krueger and Markon (2006). Copyright 2006 by Annual Review of Clinical Psychology.
Reprinted with permission.
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panic disorder, social and specific phobia [9], while others
have not found evidence of these subfactors [12].
In expanding this work to encompass rarer forms of
psychopathology, a recent study in a clinical sample ana-
lyzed data on 25 disorders, spanning both rarer and
more common disorders, as well as Axes I and II. The
best-fitting model consisted of 5 factors: (1) internalizing,
which included anxiety and eating disorders, major depres-
sive episodes, as well as cluster C (anxious and inhibited)
personality disorders, borderline and paranoid personality
disorders; (2) externalizing, including the substance use dis-
orders and antisocial personality disorder; (3) thought dis-
order, including psychosis, mania, and cluster A personality
disorders; (4) somatoform disorders; and (5) antagonism,
including cluster B and paranoid personality disorders [13].
This work is important in that it replicates findings from
previous work in a clinical sample and demonstrates
that the same methods used to establish the existence
of the internalizing-externalizing model can be used
to extend that model to rarer disorders observed in
clinical populations.
Advantages of a quantitative-empirical approach over a
case-control approach
As opposed to studies that take a meta-structure ap-
proach, studies that use a case–control design in looking
for biological correlates of specific disorders are limited
both conceptually and empirically in accommodating
comorbidity among diagnoses. Searching for biological
correlates of one specific disorder often involves designing
research to identify cases that have no or few comorbiddiagnoses, in order to maintain pure diagnostic categories.
This artificial exclusion of cases with comorbidities means
that the studies lose ecological validity, inasmuch as a typ-
ical clinical case will meet criteria for disorders in addition
to the target disorder. Such studies are therefore difficult
to extrapolate to actual clinical populations where there is
extensive diagnostic comorbidity.
By contrast, in interpreting biological findings through
the lens of psychopathological dimensions, research on
the underlying biological substrates of disorders becomes
more tractable because comorbidity is accommodated in
study design and result interpretation. Disorders do not
co-occur at random; instead, they group in predictable
ways that the meta-structure helps us anticipate, and look-
ing for correlates of these groups of disorders instead of
singular diagnoses allows researchers to better reflect the
realities of psychiatric diagnoses. Using the meta-structure
approach in biological research also allows for a purer and
stronger biological ‘signal’ by allowing disorders to co-vary
rather than losing power to artificial distinctions between
related diagnoses. The signal of the latent variable, or
what is shared between diagnoses, will necessarily be
stronger than the signal of each individual diagnosis,
and will also reduce noise due to inter-diagnostic
similarities that made it difficult to form conclusions
about disorder specificity. Conversely, in the case–
control designed study if comorbid diagnoses are
allowed in the study design, it can be challenging to
parse out the relationship between individual diagno-
ses and results with any sort of specificity, which is
supposedly the benefit of conceptualizing disorders as
separate entities.
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alizing spectrum illustrates these points. A recent review
of studies investigating affect-startle in internalizing dis-
orders found evidence that these particular biological
correlates tend to line up with the two subfactors, i.e.,
fear and distress, that are frequently found to underlie
the internalizing factor. Disorders marked by cue-
specific fear (specific and social phobia) tend to be asso-
ciated with one parameter of startle reactivity (potentiation
of startle during exposure to aversive stimuli), whereas dis-
orders marked by diffuse negative affectivity or distress
tend to be associated with others (heightened general re-
activity or increased context-potentiated startle and, pos-
sibly, decreased fear-potentiated startle). The authors
conclude that there are specific features of fear-based re-
activity that map onto the distress and fear sub-factors of
internalizing, while the overall concept of pathological
fear-based reactivity relates to the overarching internalizing
spectrum, implicating fear-potentiated startle as a likely
biological indicator of internalizing psychopathology
generally [14]. The findings in this study are made more
readily interpretable by the metastructure approach, which
supports the distinction between fear and distress disorders
under the internalizing factor. Additionally, this research
demonstrates how research on biological underpinnings
can also inform metastructure research itself by providing
plausible mechanisms that can further clarify research on
the ways in which disorders relate.
Conclusions
The search for biological correlates of psychopathology
stands to benefit from being interwoven with the empir-
ical structure of psychopathology. Models of the empirical
structure of psychopathology provide a coherent frame-
work through which to interpret biological findings, which
can accommodate comorbidity and improve ecological
validity. It is important that subsequent versions of the
DSM come to reflect the presence of the meta-structure
underlying mental disorders if it aims to reflect our
current empirical understanding of the data. A DSM-5
study group has proceeded towards the aim of represent-
ing the metastructure by developing a group of 11 ‘validat-
ing criteria’ that suggest aetiological relatedness between a
cluster of disorders. The criteria are (1) genetic factors, (2)
familiality, (3) early environmental adversity, (4) tempera-
mental antecedents, (5) neural substrates, (6) biomarkers,
(7) cognitive and emotional processing, (8) differences
and similarities in symptomatology, (9) comorbidity, (10)
course, and (11) treatment. A recent review of the litera-
ture has suggested that there is a case for the DSM to
unify related disorders under the category of internalizing,
also called emotional, disorders [15]. Although the meta-
analysis found differences between disorders in the pro-
posed cluster, specifically in the domains of cognitive andemotional processing, neural substrates, and familial stud-
ies, there were more similarities than differences in these
disorders within the 11 domains studied. The authors sug-
gest that a reorganization of the DSM to reflect this know-
ledge is possible, and further clarify that the proposed
clustering would not remove traditional diagnostic categor-
ies, but only reorganize them to better reflect our current
understanding. Although our understanding of etiology is
still in its nascent stages, to preserve the current classifica-
tion system with all its flaws until a definitive solu-
tion becomes clear would impede biologically and
diagnostically-based research [16]. Insofar as the DSM
5 will reflect changes to our understanding of the nature
of diagnostic categories, it will be progressing towards a
system that will be better suited to research biological
underpinnings.
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